Fig. 35
From: Non-FDG PET/CT in Diagnostic Oncology: a pictorial review

68Ga-PSMA, prostate cancer, biochemical recurrence (BCR): peritoneal invasion. Clinical history: 67 y.o. man with prostate cancer, radical prostatectomy as primary treatment Gleason score 4 + 3; during anti-androgen treatment, PSA increased up to PSA = 114 ng/ml. PET/CT findings: multiple foci of increased uptake in the peritoneum, liver capsule, and mediastinal lymph nodes. a MIP. b PET, fused, and CT images